Acompanhe as Notícias da Recifes

New research shows men with very low testosterone levels are at higher risk of both fatal and nonfatal cancer later in life. But while the research found men with low testosterone were 18% more likely to die of cancer years down the track, the results did not hold for prostate ca

A drug commonly used to treat type 2 diabetes has the added bonus of reducing the risk of prostate cancer, new research has found. For the study, published in Rejuvenation Research, researchers conducted a literature review of research from the past 10 years, covering 2.25 millio

A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska Institutet, the Stockholm3 blood test detected more clinically significant cancer cases than the PSA test, without subjecting more men to unnecessary testin

When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media coverage raises awareness. More men may seek information or medical advice.

New research suggests that low handgrip strength alone is not a reliable predictor of increased prostate cancer risk among older men. The relationship between low handgrip strength (HGS) and prostate cancer has long remained uncertain in the scientific literature. When clinicians

For patients with benign prostatic hyperplasia (BPH), early functional outcomes are comparable with high-peak-power pulsed Thulium:YAG laser enucleation (p-ThuLEP) and open simple prostatectomy (OSP), but shorter hospitalization and lower transfusion rates are seen with p-ThuLEP,

The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million American men, with another 330,000 men expected to be diagnosed with the condition this year alone.

A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer "cancer" does more harm than good. A new UCLA-led study found removing the cancer label could dramatically reduce overtreatment and encourage more men to get screened, potentially leadi

A new study by researchers at The University of Texas MD Anderson Cancer Center has identified genetic factors that determine whether prostate cancers are susceptible to a type of cell death known as ferroptosis. These findings, published in Nature Communications, could help guid

A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a study conducted by researchers at Umeå University together with international collaborators, published in the journal Signal Transduction and Targeted Thera

Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, can cause aggressive disease at a young age. The discovery paves the way for genetic testing programs that could help identify at-risk families and support

In the United States, prostate cancer is a leading cause of cancer-related disease and death in men. About half of prostate cancer cases in patients of European ancestry have a gene rearrangement in which the genes TMPRSS2 and ERG are fused together. This causes the ERG protein t